Location: San Antonio
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near San Antonio
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Janssen Research & Development, LLC · NCT06319820A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Phase 1 · New Experimental Therapeutics of San Antonio LLC · PAQ Therapeutics, Inc. · NCT07300150Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Phase 3 · Gruppo Oncologico Italiano di Ricerca Clinica · NCT04996017A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · START San Antonio · Pfizer · NCT05355701Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · The University of Texas Health Science Center at San Antonio · Jaeb Center for Health Research · NCT06837181First In Human Study of CX-2051 in Advanced Solid Tumors
Phase 1 · START San Antonio LLC · CytomX Therapeutics · NCT06265688A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase 1/Phase 2 · Mays Cancer Center / University of Texas, San Antonio · Phanes Therapeutics · NCT05652686MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Babcock Surgical Center · Stryker Instruments · NCT03072927Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · University of Texas Health Science Center at San Antonio · ECOG-ACRIN Cancer Research Group · NCT06002828A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · START | San Antonio · Bayer · NCT06914128CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · San Antonio Eye Center · EyePoint Pharmaceuticals, Inc. · NCT07449923A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 3 · Janssen Research & Development, LLC · NCT07164443A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectab
Phase 1/Phase 2 · University of Texas Health Science Center - San Antonio · Tvardi Therapeutics, Incorporated · NCT05440708Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
Phase N/A · University of Pittsburgh · NCT04809064A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Phase 2 · UT Health San Antonio · Intra-Cellular Therapies, Inc. · NCT06651567A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Texas Transplant Institute · Janssen Research & Development, LLC · NCT07258511European Myeloma Network (EMN) Sample Project
Phase N/A · European Myeloma Network B.V. · NCT06237803Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Par
Phase 2/Phase 3 · Pinnacle Clinical Research- San Antonio · Protara Therapeutics · NCT06910943Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metast
Phase 1 · University of Texas Health Science Center at San Antonio · Lei Zheng · NCT07086768A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Phase 1/Phase 2 · South Texas Accelerated Research Therapeutics (START) - San · Novartis Pharmaceuticals · NCT04104776Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Phase 3 · San Antonio Clinical Trials · Vertex Pharmaceuticals Incorporated · NCT06628908Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Phase 4 · San Antonio VA Medical Center · Duke University · NCT04262206Study in Advanced Solid Tumor Patients
Phase 1/Phase 2 · START San Antonio · Callio Therapeutics · NCT07300943Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Phase 3 · Texas Oncology-San Antonio · Summit Therapeutics · NCT05899608A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Phase 2/Phase 3 · Southern Star Research Institute, LLC · Janssen Research & Development, LLC · NCT07196722Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Mirati Therapeutics Inc. · NCT04613596SELUTION4BTK Trial
NA · Texas Cardiac and Vascular Institute San Antonio · M.A. Med Alliance S.A. · NCT05055297A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in
Phase 3 · Texas Dermatology and Laser Specialists /ID# 267249 · AbbVie · NCT06461897Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficien
Phase 3 · South Texas Health Care System, San Antonio, TX · VA Office of Research and Development · NCT04867317A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Phase 2 · RFSA Dermatology - San Antonio - West Avenue · Pfizer · NCT07219615
Look up another city
Look up another condition